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Scoliosis, blindness and arachnodactyly in a large Turkish
family: Is it a new syndrome?
Abstract
In this report we have described an affected sib in a large Turkish family who appears to have a new
distinct dominantly-inherited blindness, scoliosis and arachnodactyly syndrome. The combination of
clinical abnormalities in these patients did not initially suggest Marfan syndrome or other connective
tissue disorders associated with ectopia lentis. The proband was a 16-year-old boy who was referred to
our clinics for scoliosis. He had arachnodactyly of both fingers and toes. He had been suffering from
progressive visual loss and strabismus since he was eight-years-old. His 20-year-old brother had severe
kyphoscoliosis, and arachnodactyly of fingers and toes. He was 130 cm tall and was bilaterally blind.
His 23-year-old sister had only eye findings but no arachnodactyly or scoliosis. His 60-year-old father
had mild scoliosis, blindness and arachnodactyly and mother was normal. We performed routine
mutation analyses in the genes FBN1, TGFBR1 and TGFBR2, but no mutation has been detected. Our
Turkish patients are most likely affected by a hitherto unrecorded condition which is caused by an
autosomal dominant gene defect with variable expression but we can not exclude multigenic inheritance.
Further studies are needed to assess the contribution of sex influence to the syndrome because the
female relative is less affected.
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Summary 
 
In this report we have described an affected sib in a large Turkish family who appears to have 
a new distinct dominantly-inherited blindness, scoliosis and arachnodactyly syndrome. The 
combination of clinical abnormalities in these patients did not initially suggest Marfan 
syndrome or other connective tissue disorders associated with ectopia lentis. The proband was 
a 16-year-old boy who was referred to our clinics with scoliosis. He had arachnodactyly of 
both fingers and toes. He had been suffering from progressive visual loss and strabismus since 
he was eight years old. His 20-year-old brother had severe kyphoscoliosis, and 
arachnodactyly of fingers and toes. He was 130 cm tall and was bilaterally blind. His 23 year 
old sister had only eye findings but no arachnodactyly or scoliosis. His 60-year-old father had 
mild scoliosis, blindness and arachnodactyly and mother was normal. We performed routine 
mutation analyses in the genes FBN1, TGFBR1 and TGFBR2, but no mutation has been 
detected. Our Turkish patients are most likely affected by a hitherto unrecorded condition 
which is caused by an autosomal dominant gene defect with variable expression but we can 
not exclude multigenic inheritance. Further studies are needed to assess the contribution of 
sex influence to the syndrome because female relatives are less affected. 
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INTRODUCTION 
 
In this report we have described an affected sib in a large Turkish family who 
appears to have a new distinct dominantly-inherited blindness, scoliosis and arachnodactyly 
syndrome. This family has been followed since 1996. Biochemical analyses, urine analyses 
for aminoaciduria, echocardiography, and chromosomal analyses revealed normal results for 
this family. Their psychomotor development and the intellectual levels were normal. All 
affected individuals had blindness and scoliosis of variable degrees as well as arachnodactyly 
(Fig. 1, Table I). All affected family members had sufficient vision for their childhood 
activities and they started to lose vision due to lens luxation due to unknown causes between 
8-12 years of age. Ocular progress included total retinal detachment, phthisis, opaque small 
cornea and finally blindness due to retinal detachment. 
 In our literature review, we didn’t find any known syndrome equally or 
approximately matching the combination of blindness, scoliosis, and arachnodactyly as 
proposed by this report. We performed mutation analyses in the genes FBN1, TGFBR1 and 
TGFBR2 for excluding Marfan or Marfanoid syndromes. The aim of the present paper is to 
describe new genetic entity, probably autosomal dominant. 
 
CLINICAL REPORT 
 
Case 1 
 
In the first presentation, the proband (I.B) was a 16-year-old boy, referred to our clinic 
with a severe scoliosis (Figs 2a-2e). He had been operated on for this reason.  
During the second admission, he had more significant scoliosis compared to previous 
operation (Figs 2f and 3). Age of his mother was 55 and his father was 60 years old at time of 
first presentation. The parents are first cousins and their family history was unremarkable. The 
proband has two sibs with similar clinical features and five sibs were unaffected. On 
admission, the proband was 153 cm tall (<25p) with upper segment 76 cm, upper/lower 
segment ratio is 0.987 (+1 SD), and armspan 156 cm. There was arachnodactyly (>95p) (Fig. 
4) in both fingers and toes. The fourth and fifth toes were bilaterally situated in back position 
but he has neither joint laxity nor wrist and thumb signs. Furthermore, he has not any skin, 
facial, teeth, and palate malformation. We revealed no skeletal findings related to Marfan 
syndrome by whole body radiography (e.g. protrusion acetabulae, medial rotation of the 
medial malleolus).  
He had been suffering from progressive visual loss and strabismus since he was eight 
years old. Ophthalmic examination revealed esotropia in the right eye, bilateral lens luxation 
through the vitreous and atrophy of retinal elements, and hypertrophy of retinal pigment 
epithelium (Fig. 5a). Visual acuity was 0.2 with +6.0 glasses in both eyes. These findings 
were consistent with severe myopia in childhood and after lens luxation occurred he became 
hyperopic. Corneal diameters were 10 mm horizontally which was borderline microcornea. 
Two years later, we observed total retinal detachment in his right eye.  
 
Case 2 
 
Physical examination of the proband’s 20-year-old brother (S.B.) revealed severe 
kyphoscoliosis and arachnodactyly bilaterally in both fingers and toes (Figs 7a, 7b, 7c). He 
was 130 cm tall. His ophthalmic examination revealed bilateral phthisic, totally opaque and 
small lenses and complete blindness. He has neither skin and facial malformation nor joint 
laxity. 
Case 3 
 
The proband’s 23-year-old sister (U.B.) also had only eye findings but no 
arachnodactyly or scoliosis (Fig. 6). She was 150 cm tall. Ophthalmic examination revealed 
bilateral phthisic, totally opaque and small lenses and absolute blind eyes (Fig. 5b). She has 
neither skin and facial malformation nor joint laxity. 
 
Case 4  
 
The proband’s 60-year-old father (M.B) had mild scoliosis, blindness, and 
arachnodactyly. He was 160 cm tall. He has neither skin and facial malformation nor joint 
laxity. 
 
Methods and Results 
 
DNA Extraction 
Genomic DNA was extracted starting from 2 ml of peripheral blood of the affected 
patients, using commercial kit (Flexigene, Qiagen). 
 
Molecular Analyses of FBN1, TGFBR1 and TGFBR2  
For polymerase chain reaction (PCR) amplification of all the 65 exons of the FBN1 
gene, a set of 65 pairs of primers (Sigma-Genosys, Pampisford, Cambridgeshire, UK) was 
used, including flanking splice sites. The oligonucleotide sequences were those described in 
previous studies (7,14,19). Genomic DNA (100-200 ng) was amplified with 5-10 pmol from 
each pair of primers, 200 µM each dNTPs, 1.0-1.5 mM MgCl2, 1x PCR buffer, and 1-2 U Taq 
DNA polymerase, in a final volume of 25-50 µl. All PCR reagents except primers were 
supplied by Invitrogen. The amplifications were performed under the following variable 
conditions: one cycle of denaturation for 5’ at 95°C, followed by 30-35 cycles of denaturation 
(30” at 95°C), annealing (30” at 52°-58°C, depending on the fragment) and extension (30” at 
72°C), followed by a 5’ final extension step at 72°C. A small aliquot of each PCR sample, 
together with a molecular weight marker, was run on agarose gel and stained with ethidium 
bromide to confirm PCR amplification and size of the fragment. Mutation screening was 
carried out employing a dHPLC method, using a WAVE Nucleic Acid Fragment Analysis 
system (Transgenomic). The PCR samples were injected into a DNASep Column and run 
using protocols and conditions determined using Wavemaker software (V. 4.2), following 
manufacturer’s directions. 
For the TGFBR1 and TGFBR2 genes, all exons and flanking intronic regions were 
amplified and directly sequenced under routine conditions as described elsewhere (15). 
In order to detect large genomic rearrangements, multiplex ligation-dependent probe 
amplification (MLPA) was carried out using the SALSA kits P065 (probes for FBN1 
and TGFBR2), P066 (probes for FBN1), and P148 (probes for both TGFBR1 and 
TGFBR2), commercially available from MRC-Holland (Amsterdam, The 
Netherlands) as previously described (16).  
 As a result we didn’t find any mutation in FBN1, TGFBR1 and TGFBR2 genes. 
DISCUSSION 
 
 Nontraumatic subluxation or dislocation of the crystalline lens is most commonly 
observed in Marfan syndrome. It is also a major manifestation of homocystinuria, the Weill -
Marchesani syndrome and a few less common autosomal recessive disorders (31). 
Radiographically defined scoliosis has many causes (20). The hereditary 
musculoskeletal disorders, such as osteogenesis imperfecta (28), Marfan syndrome (12), 
Stickler syndrome (9), Ehlers-Danlos syndrome (23) and the muscular dystrophies (30) can all 
include scoliosis as a manifestation. Neuromuscular diseases, such as spina bifida, cerebral 
palsy, and myelomeningocele are associated with the development of scoliosis, secondary to 
muscle imbalance (3,26). Paralytic disorders resulting from polio or spinal trauma lead to a 
progressive scoliosis. Radiation therapy, tumors, and syrinx formation have also been 
implicated among the causes of scoliosis. However, at least 80% of all scoliosis is classified 
as idiopathic (IS) because no cause can be identified. Evidence for a genetic component to IS 
is strong, but support for any specific mode of inheritance is limited. 
 Marfan syndrome [MFS] is an autosomal dominant heritable disorder of connective 
tissue that involves many systems [skeletal, ocular, cardiovascular, pulmonary, skin and 
integument, and dura] but its more prominent manifestations are skeletal, ocular, and 
cardiovascular. MFS is the result of mutations in the FBN1 gene (11). In previous studies, 
however, extensive mutational analyses failed to show FBN1 involvement in almost 10% or 
more of patients with MFS satisfying the Ghent criteria. That patients were shown to have 
mutations in the TGFBR2 gene, which encodes the transmembrane receptor type II of TGFβ 
(8). A wide variety of skeletal abnormalities occurs with MFS including dolichostenomelia, 
arachnodactyly, scoliosis, chest wall deformity [pectus carinatum or excavatum], tall stature, 
ligamentous laxity, abnormal joint mobility, and protrusio acetabulae. Scoliosis is found in 
about 60% of adults of both sexes with MFS (21). Pectus excavatum of some degree of 
severity occurs in about two thirds of all MFS patients, and may have a greater tendency to 
reoccur after surgical repair than idiopathic pectus excavatum (15). Ectopia lentis occurs in up 
to 80% of MFS patients and is almost always bilateral (6). The most common cardiovascular 
manifestations of MFS affect the atrioventricular valves and the aorta. The diagnosis of MFS 
can be made according to the criteria of Ghent nosology (10). Diagnostic dilemmas may arise 
because of the considerable inter- and intrafamilial variability of MFS. Also, many features of 
MFS, such as mitral valve prolapse or scoliosis, are common in the general population or may 
occur in other connective tissue disorders and many manifestations are age dependent. 
Arachnodactyly, scoliosis, and lens subluxation may be seen in MFS but low vision in early 
childhood and progression of visual loss are uncommon in this syndrome. In addition, 
bilateral anterior microphthalmos, bilateral microcornea, and corneal opacity are not present 
in MFS and the direction of lens dislocation is typically superotemporal. In our patients the 
direction of lens dislocation was inferior and our patients’ intelligence and echocardiograms 
were normal and our patients do not fulfill Ghent criteria. 
FBN1 mutations have been identified in complete and incomplete forms of MFS, 
including severe neonatal MFS, dominantly inherited ectopia lentis, isolated skeletal features 
of MFS such as kyphoscoliosis. The new molecular group of ‘type-1 fibrillinopathies’ 
comprises a spectrum of overlapping diseases including the Shprintzen–Goldberg syndrome 
and, more recently, familial or isolated forms of aortic aneurysms (13). However, neither 
FBN1 nor TGFBR1/2 molecular genetic testing revealed any mutation in our proband.. Hence, 
either our mutation screening has failed to identify a disease-causing mutation or the clinical 
conditions reported are not part of the deficiency spectrum of FBN1, TGFBR1 and TGFBR2. 
In this family, all members suffered from poor vision in early childhood and within a 
few years they lost their vision. Similar findings may also be found in Stickler syndrome. 
Stickler syndrome is an autosomal dominant connective tissue disorder that can include ocular 
findings of myopia, cataract, and retinal detachment; hearing loss that is both conductive and 
sensorineural, midfacial underdevelopment and cleft palate [either alone or as part of the 
Robin sequence], mild spondyloepiphyseal dysplasia and/or precocious arthritis (19), but 
dislocation of the lens is not seen in Stickler syndrome and our patients had no hearing loss, 
cleft palate, and cataract. 
The kyphoscoliotic type of Ehlers–Danlos syndrome [EDS VIA] [MIM 225400] is an 
inherited connective tissue disorder. It is clinically characterized by severe muscular 
hypotonia at birth, kyphoscoliosis, which is present at birth or starts in early infancy and is 
progressive, and severe joint hypermobility and luxation (14). In addition there is often a 
marfanoid habitus, osteopenia without a tendency to fractures, fragility of the skin with 
abnormal scarring, microcornea, and rupture of the arteries and the eye globe (7). The 
diagnosis is often considered very late. Because of the severe muscular hypotonia and delay in 
gross motor development a neuromuscular disease is often suspected, especially when 
deformities of the feet and joint dislocations coexist, and therefore an extensive, often 
invasive, neuromuscular work-up is usually performed with normal results (28). However, 
clinical features and timing of onset in our cases does not fit with this diagnosis. 
 We thought that myopia, lens dislocation, retinal detachment and other unknown 
causes probably lead to blindness and phthisis in this family. Although there are certain 
similarities between our cases and other known genetic conditions, our literature review and 
the London Dysmorphology Database (33) did not show any other known syndrome equally 
or approximately matching the combination of blindness, scoliosis, and arachnodactyly as 
proposed by this report.  
 Our Turkish patients are most likely affected by a hitherto unreported condition 
caused by an autosomal dominant gene defect with variable expression but we can not 
exclude multigenic additives. Sex- influence has probably contributed to the disease 
inheritance because the proband’s mother and sister are less affected than the his brother and 
father. 
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LEGENDS 
FIGURE 1. Family’s pedigree 
FIGURE 2a, 2b, 2c; the first admission of the proband (I.B).  
2d; after the operation of his scoliosis. 2e : a few years later. 
2fa,2fb :Progressive scoliosis.  
FIGURE 3. X-ray of I.B.  
FIGURE 4. Arachnodactyly.  
FIGURE 5a and 5b. Eye pictures of the proband I.B and case U.B, respectively. 
FIGURE 6. Case U.B. 
FIGURE 7a, 7b, 7c; Case S.B when he was 20 years old. 
 
 
 
